ConcentRx, Inc. — TTAB Proceedings
ConcentRx, Inc. is a party to 2 TTAB proceedings.
Proceedings
- Proceeding 91238217 — Oppositions, Terminated (filed 2017-12-06) against Concentrx Pharmaceuticals, Inc. as defendant
- Proceeding 87398372 — Extensions of Time to Oppose, Terminated (filed 2017-09-05) against Novartis AG as defendant
Marks in These TTAB Matters
Common TTAB Counterparties
- Concentrx Pharmaceuticals, Inc. — 1 proceedings
- Novartis AG — 1 proceedings
Recent TTAB Timeline
- 2018-03-22: 91238217 — TERMINATED involving Concentrx Pharmaceuticals, Inc.
- 2018-03-22: 91238217 — BOARD'S DECISION: SUSTAINED involving Concentrx Pharmaceuticals, Inc.
- 2018-01-25: 91238217 — NOTICE OF DEFAULT involving Concentrx Pharmaceuticals, Inc.
- 2017-12-06: 91238217 — PENDING, INSTITUTED involving Concentrx Pharmaceuticals, Inc.
- 2017-12-06: 91238217 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Concentrx Pharmaceuticals, Inc.
- 2017-12-06: 91238217 — FILED AND FEE involving Concentrx Pharmaceuticals, Inc.
- 2017-10-04: 87398372 — EXTENSION OF TIME GRANTED involving Novartis AG
- 2017-10-04: 87398372 — INCOMING - EXT TIME TO OPPOSE FILED involving Novartis AG
- 2017-09-05: 87398372 — EXTENSION OF TIME GRANTED involving Novartis AG
- 2017-09-05: 87398372 — INCOMING - EXT TIME TO OPPOSE FILED involving Novartis AG
- 2017-09-05: 87398372 — EXTENSION OF TIME GRANTED involving Novartis AG
- 2017-09-05: 87398372 — INCOMING - EXT TIME TO OPPOSE FILED involving Novartis AG